I hold both Merck & JNJ stock. Clearly, JNJ is the lessor in this fight, and it losts badly. Very disappointed with Russ Deyo performance - the legal guy. The legal maneuver by Merck during its merge was known by everyone and JNJ legal did not have any move to protect the shareholder interest. I think Russ should return his multi-million bonus back to the company.